Last reviewed · How we verify

NCT05223153

OCT-A and Amblyopia

Completed Last updated 2 November 2022
What this trial tests

trial testing Optical Coherence tomography angiography in Amblyopia in 32 participants. Completed in 30 September 2022.

Timeline
15 September 2021
Primary endpoint
1 August 2022
30 September 2022

Quick facts

Lead sponsorMinia University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment32
Start date15 September 2021
Primary completion1 August 2022
Estimated completion30 September 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Minia University

Who can join

Adults 6 to 12, any sex, with Amblyopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Detect changes in retinal vessel density in the superficial and deep capillary plexuses using OCTA in children with anisometropic amblyopia

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Assessment of macular microvascular changes in children following treatment of anisometropic myopic amblyopia using optical coherence tomography angiography.
    AttaAllah HR, Abdelaziz STA, Mohamed AAM, Ibrahiem MFK. · · 2023 · cited 2× · PMID 37052667 · DOI 10.1007/s00417-023-06055-8

Verify or expand the search:

Other recruiting trials for Amblyopia

Currently open trials in the same condition.

Other Minia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05223153.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing